Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2022 May 19

PMID 35587600

Authors

Marciana L Laster

Bryce Rowan

Hua-Chang Chen

Tae-Hwi Schwantes-An

Xin Sheng

Peter A Friedman

T Alp Ikizler

Janet S Sinshiemer

Joachim H Ix

Katalin Susztak

Ian H de Boer

Bryan Kestenbaum

Adriana Hung

Sharon M Moe

Farzana Perwad

Cassianne Robinson-Cohen

Affiliations

Soon will be listed here.

Abstract

Context: Chronic kidney disease (CKD) causes multiple interrelated disturbances in mineral metabolism. Genetic studies in the general population have identified common genetic variants associated with circulating phosphate, calcium, parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23).

Objective: In this study we aimed to discover genetic variants associated with circulating mineral markers in CKD.

Methods: We conducted candidate single-nucleotide variation (SNV) analysis in 3027 participants in the multiethnic Chronic Renal Insufficiency Cohort (CRIC) to determine the associations between SNVs and circulating levels of mineral markers.

Results: SNVs adjacent to or within genes encoding the regulator of G protein-coupled signaling 14 (RGS14) and the calcium-sensing receptor (CASR) were associated with levels of mineral metabolites. The strongest associations (P < .001) were at rs4074995 (RGS14) for phosphate (0.09 mg/dL lower per minor allele) and FGF23 (8.6% lower), and at rs1801725 (CASR) for calcium (0.12 mg/dL higher). In addition, the prevalence of hyperparathyroidism differed by rs4074995 (RGS14) genotype (chi-square P < .0001). Differential inheritance by race was noted for the minor allele of RGS14. Expression quantitative loci (eQTL) analysis showed that rs4074995 was associated with lower RGS14 gene expression in glomeruli (P = 1.03 × 10-11) and tubules (P = 4.0 × 10-4).

Conclusion: We evaluated genetic variants associated with mineral metabolism markers in a CKD population. Participants with CKD and the minor allele of rs4074995 (RGS14) had lower phosphorus, lower plasma FGF23, and lower prevalence of hyperparathyroidism. The minor allele of RGS14 was also associated with lower gene expression in the kidney. Further studies are needed to elucidate the effect of rs4074995 on the pathogenesis of disordered mineral metabolism in CKD.

Citing Articles

Calcium-sensing receptor genetic variants and their association with CKD-MBD in South Indian Tamils.

Priyadarshini G, Dhinesh A, Parameswaran S, Sahoo J, Selvarajan S, Rajappa M J Appl Genet. 2025; .

PMID: 40085338 DOI: 10.1007/s13353-025-00955-7.

The Intricacies of Renal Phosphate Reabsorption-An Overview.

Walker V Int J Mol Sci. 2024; 25(9).

PMID: 38731904 PMC: 11083860. DOI: 10.3390/ijms25094684.

Multi-trait Analysis of GWAS for circulating FGF23 Identifies Novel Network Interactions Between HRG-HMGB1 and Cardiac Disease in CKD.

Perwad F, Akwo E, Vartanian N, Suva L, Friedman P, Robinson-Cohen C medRxiv. 2024; .

PMID: 38496593 PMC: 10942519. DOI: 10.1101/2024.03.04.24303051.

Molecular mechanism of Decoction in treating chronic kidney disease based on network pharmacology.

Lan X, Ao W, Li J Am J Transl Res. 2024; 15(12):6878-6887.

PMID: 38186988 PMC: 10767527.

Understanding renal phosphate handling: unfinished business.

Lederer E Curr Opin Nephrol Hypertens. 2023; 32(4):394-400.

PMID: 37070493 PMC: 11441352. DOI: 10.1097/MNH.0000000000000889.

References

Moe S, Wetherill L, Decker B, Lai D, Abdalla S, Long J . Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis. Clin J Am Soc Nephrol. 2017; 12(7):1128-1138. PMC: 5498355. DOI: 10.2215/CJN.11141016. View

Isakova T, Gutierrez O, Smith K, Epstein M, Keating L, Juppner H . Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant. 2010; 26(2):584-91. PMC: 3108359. DOI: 10.1093/ndt/gfq419. View

Conigrave A, Ward D . Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. Best Pract Res Clin Endocrinol Metab. 2013; 27(3):315-31. DOI: 10.1016/j.beem.2013.05.010. View

Friedman P, Sneddon W, Mamonova T, Montanez-Miranda C, Ramineni S, Harbin N . RGS14 regulates PTH- and FGF23-sensitive NPT2A-mediated renal phosphate uptake via binding to the NHERF1 scaffolding protein. J Biol Chem. 2022; 298(5):101836. PMC: 9035407. DOI: 10.1016/j.jbc.2022.101836. View

Parsa A, Kanetsky P, Xiao R, Gupta J, Mitra N, Limou S . Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study. J Am Soc Nephrol. 2016; 28(3):923-934. PMC: 5328149. DOI: 10.1681/ASN.2015101152. View

Wang L, Feng C, Ding G, Lin X, Gao P, Jiang H . Association Study of Reported Significant Loci at 5q35.3, 7p14.3, 13q14.1 and 16p12.3 with Urolithiasis in Chinese Han Ethnicity. Sci Rep. 2017; 7:45766. PMC: 5374640. DOI: 10.1038/srep45766. View

Willer C, Li Y, Abecasis G . METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010; 26(17):2190-1. PMC: 2922887. DOI: 10.1093/bioinformatics/btq340. View

Chen W, Chou W, Chu H, Huang C, Liu X, Chang W . The rs1256328 (ALPL) and rs12654812 (RGS14) Polymorphisms are Associated with Susceptibility to Calcium Nephrolithiasis in a Taiwanese population. Sci Rep. 2019; 9(1):17296. PMC: 6872875. DOI: 10.1038/s41598-019-53261-8. View

Jovanovich A, Chonchol M, Cheung A, Kaufman J, Greene T, Roberts W . Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clin J Am Soc Nephrol. 2012; 7(4):640-7. PMC: 3315341. DOI: 10.2215/CJN.07020711. View

10.

OSeaghdha C, Wu H, Yang Q, Kapur K, Guessous I, Zuber A . Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet. 2013; 9(9):e1003796. PMC: 3778004. DOI: 10.1371/journal.pgen.1003796. View

11.

Tin A, Kottgen A . Genome-Wide Association Studies of CKD and Related Traits. Clin J Am Soc Nephrol. 2020; 15(11):1643-1656. PMC: 7646230. DOI: 10.2215/CJN.00020120. View

12.

Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W . Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2019; 75(2):235-244. PMC: 7012684. DOI: 10.1053/j.ajkd.2019.07.022. View

13.

Robinson-Cohen C, Hoofnagle A, Ix J, Sachs M, Tracy R, Siscovick D . Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA. 2013; 310(2):179-88. PMC: 4150653. DOI: 10.1001/jama.2013.7228. View

14.

Grzegorzewska A, Bednarski D, Swiderska M, Mostowska A, Jagodzinski P . The Calcium-Sensing Receptor Gene Polymorphism rs1801725 and Calcium-Related Phenotypes in Hemodialysis Patients. Kidney Blood Press Res. 2018; 43(3):719-734. DOI: 10.1159/000489747. View

15.

Qiu C, Huang S, Park J, Park Y, Ko Y, Seasock M . Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med. 2018; 24(11):1721-1731. PMC: 6301011. DOI: 10.1038/s41591-018-0194-4. View

16.

Feldman H, Appel L, Chertow G, Cifelli D, Cizman B, Daugirdas J . The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003; 14(7 Suppl 2):S148-53. DOI: 10.1097/01.asn.0000070149.78399.ce. View

17.

Jones G, Prosser D, Kaufmann M . 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2011; 523(1):9-18. DOI: 10.1016/j.abb.2011.11.003. View

18.

Yang W, Ma F, Wang L, He X, Zhang H, Zheng J . The association analysis between CYP24A1 genetic polymorphisms and the risk of ischemic stroke in Chinese Han population. Brain Behav. 2019; 10(2):e01503. PMC: 7010572. DOI: 10.1002/brb3.1503. View

19.

Das S, Forer L, Schonherr S, Sidore C, Locke A, Kwong A . Next-generation genotype imputation service and methods. Nat Genet. 2016; 48(10):1284-1287. PMC: 5157836. DOI: 10.1038/ng.3656. View

20.

. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2019; 7(1):1-59. PMC: 6340919. DOI: 10.1016/j.kisu.2017.04.001. View